New professor at the University of Basel’s institute for eye research
The new Institute of Molecular and Clinical Ophthalmology Basel (IOB) from the University of Basel, University Hospital Basel and Novartis is gaining a new professor: Carlo Rivolta has been appointed Full Professor by the University Council.
01 March 2019
The University Council has appointed Carlo Rivolta as Full Professor for Ophthalmic Genetics and Genetic Epidemiology at the Faculty of Medicine; he will work at the IOB. Prof. Rivolta is currently Head of a research group at the University of Lausanne and Professor of Medical Genetics at the University of Leicester, UK. At the IOB, which was founded at the end of 2017, basic researchers and clinicians work together in order to advance our understanding of vision and of its associated pathologies, as well as to develop new treatments for combating visual loss.
Prof. Rivolta was born in 1970 in Monza, Italy, and studied molecular biology at the University of Pavia and then Lausanne, where he earned his doctorate in molecular genetics in 1999. During his four-year postdoctoral fellowship at Harvard Medical School (Massachusetts Eye and Ear Infirmary) in Boston, he was involved in the discovery of new disease genes and mutations that lead to retinal degeneration.
In 2004, Prof. Rivolta returned to the University of Lausanne, taking on the position of Junior Group Leader at the Department of Medical Genetics; he then became Head of a research group there in 2008. His habilitation followed in 2012, and in 2017 he was appointed Full Professor at the University of Leicester. His scientific interests include the molecular genetics of hereditary retinal diseases.
Further information
Christoph Dieffenbacher, University of Basel, Communications & Marketing, Tel. +41 61 207 30 15, email: ch.dieffenbacher@unibas.ch
Image
A high-resolution image for this press release is available in the media database.
